Obigen Pharma Inc. (TPEX:7876)
Taiwan · Delayed Price · Currency is TWD 36.35
-0.15 (-0.41%)
At close: Jun 18, 2026
Obigen Pharma Market Cap
Obigen Pharma has a market cap or net worth of 3.89 billion as of June 18, 2026.
Market Cap
3.89B
Enterprise Value
3.45B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
36.35
Market Cap Chart
Since November 24, 2025, Obigen Pharma's market cap has decreased from 4.62B to 3.89B, a decrease of -15.86%. That is a compound annual growth rate of -26.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 3.89B | -6.79% |
| Dec 31, 2025 | 4.17B | -9.72% |
| Nov 24, 2025 | 4.62B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HanchorBio | 21.39B |
| Elixiron Immunotherapeutics (Cayman) Limited | 9.53B |
| Tripartite Therapeutics | 8.11B |
| Intelligene | 6.61B |
| Uwell Biopharma | 6.57B |
| Pet Pharm Biotech | 2.90B |
| BIONET Therapeutics | 2.58B |
| FullHope Biomedical | 1.17B |